- The Wall Street Journal•2 hours ago
While most U.S. stocks rallied on Wednesday, shares of biotechnology and pharmaceutical companies retreated after President-elect Donald Trump vowed in a magazine article to crack down on drug prices.
- Financial Times•8 hours ago
US biotechnology shares faced the sharpest sell-off in more than a month after comments from Donald Trump brought the spectre of tougher drug-price regulation back to the fore. Mr Trump's win in last month's ...
- Investor's Business Daily•11 hours ago
The market is rallying broadly late Wednesday and the Nasdaq and big-cap techs are regaining strength. Apple is back above a prior entry.
BIIB : Summary for Biogen Inc. - Yahoo Finance
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||280.50 - 288.97|
|52 Week Range||223.02 - 333.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.14|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|